ID

31499

Description

Tolvaptan Phase 3 Efficacy and Safety Study in ADPKD; ODM derived from: https://clinicaltrials.gov/show/NCT00428948

Lien

https://clinicaltrials.gov/show/NCT00428948

Mots-clés

Versions (1)
  1. 28/08/2018 28/08/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

28 août 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Polycystic Kidney Disease, Autosomal Dominant NCT00428948

Anglais

Eligibility Polycystic Kidney Disease, Autosomal Dominant NCT00428948

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
gfr estimated at ≥60 ml/ min
Description

Estimated Glomerular Filtration Rate

Type de données

boolean

Alias
UMLS CUI [1]
C3811844
diagnosis of adpkd and rapidly progressive kidney growth (total volume ≥750 cc) by magnetic resonance imaging (mri) at randomization
Description

Autosomal Dominant Polycystic Kidney Disease | Kidney Growth Rapidly progressive MRI | Kidney Total Volume MRI

Type de données

boolean

Alias
UMLS CUI [1]
C0085413
UMLS CUI [2,1]
C0022646
UMLS CUI [2,2]
C0018270
UMLS CUI [2,3]
C1838681
UMLS CUI [2,4]
C0024485
UMLS CUI [3,1]
C0022646
UMLS CUI [3,2]
C0449468
UMLS CUI [3,3]
C0024485
legal adult age and able to give informed consent
Description

Legal Adult | Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C1706450
UMLS CUI [2]
C0021430
willingness to comply with reproductive precautions if female
Description

Gender | Contraceptive methods Willing

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0700589
UMLS CUI [2,2]
C0600109
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior exposure to tolvaptan or other experimental pkd therapies
Description

Exposure to Tolvaptan | Exposure to Experimental Therapies Polycystic Kidney Diseases

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C1176308
UMLS CUI [2,1]
C0332157
UMLS CUI [2,2]
C0949266
UMLS CUI [2,3]
C0022680
currently taking medication for purpose of affecting pkd cysts
Description

Pharmaceutical Preparations Affecting PKD Cysts

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0022680
UMLS CUI [1,4]
C0010709
women who are breast feeding and females of childbearing potential who are not using acceptable contraceptive methods
Description

Breast Feeding | Childbearing Potential Contraceptive methods Absent

Type de données

boolean

Alias
UMLS CUI [1]
C0006147
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C0332197
in the opinion of the study investigator or sponsor may present a safety risk or confound study objectives
Description

Safety Risk | Interference Study Protocol

Type de données

boolean

Alias
UMLS CUI [1,1]
C0036043
UMLS CUI [1,2]
C0035647
UMLS CUI [2,1]
C0521102
UMLS CUI [2,2]
C2348563
patients who are unlikely to adequately comply with study procedures
Description

Protocol Compliance Unlikely

Type de données

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C0750558
patients having contraindications to mri
Description

Medical contraindication MRI

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0024485
patients taking medications or having any illnesses likely to affect adpkd outcomes.
Description

Pharmaceutical Preparations Affecting Autosomal Dominant Polycystic Kidney Disease Outcome | Illness Affecting Autosomal Dominant Polycystic Kidney Disease Outcome

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0085413
UMLS CUI [1,4]
C1274040
UMLS CUI [2,1]
C0221423
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0085413
UMLS CUI [2,4]
C1274040
Retour au début de la page

Similar models

Eligibility Polycystic Kidney Disease, Autosomal Dominant NCT00428948

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Estimated Glomerular Filtration Rate
Item
gfr estimated at ≥60 ml/ min
boolean
C3811844 (UMLS CUI [1])
Autosomal Dominant Polycystic Kidney Disease | Kidney Growth Rapidly progressive MRI | Kidney Total Volume MRI
Item
diagnosis of adpkd and rapidly progressive kidney growth (total volume ≥750 cc) by magnetic resonance imaging (mri) at randomization
boolean
C0085413 (UMLS CUI [1])
C0022646 (UMLS CUI [2,1])
C0018270 (UMLS CUI [2,2])
C1838681 (UMLS CUI [2,3])
C0024485 (UMLS CUI [2,4])
C0022646 (UMLS CUI [3,1])
C0449468 (UMLS CUI [3,2])
C0024485 (UMLS CUI [3,3])
Legal Adult | Informed Consent
Item
legal adult age and able to give informed consent
boolean
C1706450 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Gender | Contraceptive methods Willing
Item
willingness to comply with reproductive precautions if female
boolean
C0079399 (UMLS CUI [1])
C0700589 (UMLS CUI [2,1])
C0600109 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Exposure to Tolvaptan | Exposure to Experimental Therapies Polycystic Kidney Diseases
Item
prior exposure to tolvaptan or other experimental pkd therapies
boolean
C0332157 (UMLS CUI [1,1])
C1176308 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0949266 (UMLS CUI [2,2])
C0022680 (UMLS CUI [2,3])
Pharmaceutical Preparations Affecting PKD Cysts
Item
currently taking medication for purpose of affecting pkd cysts
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0022680 (UMLS CUI [1,3])
C0010709 (UMLS CUI [1,4])
Breast Feeding | Childbearing Potential Contraceptive methods Absent
Item
women who are breast feeding and females of childbearing potential who are not using acceptable contraceptive methods
boolean
C0006147 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Safety Risk | Interference Study Protocol
Item
in the opinion of the study investigator or sponsor may present a safety risk or confound study objectives
boolean
C0036043 (UMLS CUI [1,1])
C0035647 (UMLS CUI [1,2])
C0521102 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
Protocol Compliance Unlikely
Item
patients who are unlikely to adequately comply with study procedures
boolean
C0525058 (UMLS CUI [1,1])
C0750558 (UMLS CUI [1,2])
Medical contraindication MRI
Item
patients having contraindications to mri
boolean
C1301624 (UMLS CUI [1,1])
C0024485 (UMLS CUI [1,2])
Pharmaceutical Preparations Affecting Autosomal Dominant Polycystic Kidney Disease Outcome | Illness Affecting Autosomal Dominant Polycystic Kidney Disease Outcome
Item
patients taking medications or having any illnesses likely to affect adpkd outcomes.
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0085413 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,4])
C0221423 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0085413 (UMLS CUI [2,3])
C1274040 (UMLS CUI [2,4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial